FDA authorizes Pfizer COVID-19 vaccine for kids ages 12 to 15
The U.S. Food and Drug Administration on Monday expanded emergency use authorization for Pfizer-BioNTech?s COVID-19 vaccine in the United States for older children ages 12 to 15.
The U.S. Food and Drug Administration on Monday expanded emergency use authorization for Pfizer-BioNTech?s COVID-19 vaccine in the United States for older children ages 12 to 15.